GF
BPMC

Gabelli Funds’s Blueprint Medicines BPMC Stock Holding History

Gabelli Funds’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-211,169
Closed -$27.1M – 1251
2025
Q2 		$27.1M Buy
+211,169
New +$21.9M 0.19% 130

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Gabelli Funds's BPMC Position: Q3 2025 in Review

Gabelli Funds sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 211,169 shares — an estimated $27.1M sold.

Gabelli Funds first reported a position in BPMC in Q2 2025 and held it in 1 quarter. The position peaked at $27.1M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Gabelli Funds reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Gabelli Funds sold 211,169 Blueprint Medicines shares in Q3 2025, an estimated $27.1M.
  • Gabelli Funds first reported a position in Blueprint Medicines in Q2 2025 and held it in 1 quarter.
  • Gabelli Funds's Blueprint Medicines position peaked at $27.1M in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Gabelli Funds's 13F filing for Q3 2025, filed 12 Nov 2025.